198 related articles for article (PubMed ID: 21786236)
1. [The association of Serenoa repens, lycopene and selenium is superior to Serenoa repens alone in reducing benign prostatic hyperplasia].
Squadrito F; Morgia G
Urologia; 2011; 78(4):297-9. PubMed ID: 21786236
[TBL] [Abstract][Full Text] [Related]
2. Serenoa Repens, lycopene and selenium: a triple therapeutic approach to manage benign prostatic hyperplasia.
Minutoli L; Bitto A; Squadrito F; Marini H; Irrera N; Morgia G; Passantino A; Altavilla D
Curr Med Chem; 2013; 20(10):1306-12. PubMed ID: 23432584
[TBL] [Abstract][Full Text] [Related]
3. The combination of Serenoa repens, selenium and lycopene is more effective than serenoa repens alone to prevent hormone dependent prostatic growth.
Altavilla D; Bitto A; Polito F; Irrera N; Marini H; Arena S; Favilla V; Squadrito F; Morgia G; Minutoli L
J Urol; 2011 Oct; 186(4):1524-9. PubMed ID: 21855911
[TBL] [Abstract][Full Text] [Related]
4. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene.
Minutoli L; Altavilla D; Marini H; Rinaldi M; Irrera N; Pizzino G; Bitto A; Arena S; Cimino S; Squadrito F; Russo GI; Morgia G
J Biomed Sci; 2014 Mar; 21(1):19. PubMed ID: 24606563
[TBL] [Abstract][Full Text] [Related]
6. Survivin and NAIP in Human Benign Prostatic Hyperplasia: Protective Role of the Association of Serenoa repens, Lycopene and Selenium from the Randomized Clinical Study.
Morgia G; Micali A; Rinaldi M; Irrera N; Marini H; Puzzolo D; Pisani A; Privitera S; Russo GI; Cimino S; Ieni A; Trichilo V; Altavilla D; Squadrito F; Minutoli L
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28327526
[TBL] [Abstract][Full Text] [Related]
7. Effect of Serenoa repens, lycopene, and selenium on proinflammatory phenotype activation: an in vitro and in vivo comparison study.
Bonvissuto G; Minutoli L; Morgia G; Bitto A; Polito F; Irrera N; Marini H; Squadrito F; Altavilla D
Urology; 2011 Jan; 77(1):248.e9-16. PubMed ID: 21109292
[TBL] [Abstract][Full Text] [Related]
8. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
[TBL] [Abstract][Full Text] [Related]
9. Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between single or combination therapy (PROCOMB trial).
Morgia G; Russo GI; Voce S; Palmieri F; Gentile M; Giannantoni A; Blefari F; Carini M; Minervini A; Ginepri A; Salvia G; Vespasiani G; Santelli G; Cimino S; Allegro R; Collura Z; Fragalà E; Arnone S; Pareo RM
Prostate; 2014 Nov; 74(15):1471-80. PubMed ID: 25154739
[TBL] [Abstract][Full Text] [Related]
10. Effects of different natural extracts in an experimental model of benign prostatic hyperplasia (BPH).
Paterniti I; Campolo M; Cordaro M; Siracusa R; Filippone A; Esposito E; Cuzzocrea S
Inflamm Res; 2018 Jul; 67(7):617-626. PubMed ID: 29679313
[TBL] [Abstract][Full Text] [Related]
11. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
12. Effect of Serenoa Repens on Oxidative Stress, Inflammatory and Growth Factors in Obese Wistar Rats with Benign Prostatic Hyperplasia.
Colado-Velázquez J; Mailloux-Salinas P; Medina-Contreras J; Cruz-Robles D; Bravo G
Phytother Res; 2015 Oct; 29(10):1525-31. PubMed ID: 26104840
[TBL] [Abstract][Full Text] [Related]
13. Letter to the editorResponse to: Russo A, Capogrosso P, La Croce G, et al. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opin Drug Saf. 2016 Jun;1:1-10.
Arena S
Expert Opin Drug Saf; 2016 Oct; 15(10):1449. PubMed ID: 27558894
[No Abstract] [Full Text] [Related]
14. Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study).
Morgia G; Vespasiani G; Pareo RM; Voce S; Madonia M; Carini M; Ingrassia A; Terrone C; Gentile M; Carrino M; Giannantoni A; Blefari F; Arnone S; Santelli G; Russo GI;
BJU Int; 2018 Aug; 122(2):317-325. PubMed ID: 29569389
[TBL] [Abstract][Full Text] [Related]
15. Activity of Serenoa repens, lycopene and selenium on prostatic disease: evidences and hypotheses.
Magri V; Trinchieri A; Perletti G; Marras E
Arch Ital Urol Androl; 2008 Jun; 80(2):65-78. PubMed ID: 18683812
[TBL] [Abstract][Full Text] [Related]
16. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
Ooi SL; Pak SC
J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
[TBL] [Abstract][Full Text] [Related]
17. Serenoa repens for benign prostatic hyperplasia.
Wilt T; Ishani A; Mac Donald R
Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
[TBL] [Abstract][Full Text] [Related]
18. [A comparative analysis of the effectiveness of serenoa repens and serenoa repens in combination with urtica dioiccus for lower urinary symptoms suggestive of benign prostatic hyperplasia associated with chronic inflammation in prostate tissue].
Ibishev KS; Krainy PA; Mitusov VV; Sizyakin DV; Magomedov GA
Urologiia; 2019 Apr; (1):40-46. PubMed ID: 31184016
[TBL] [Abstract][Full Text] [Related]
19. Botanical derivatives for the prostate.
Cristoni A; Di Pierro F; Bombardelli E
Fitoterapia; 2000 Aug; 71 Suppl 1():S21-8. PubMed ID: 10930709
[TBL] [Abstract][Full Text] [Related]
20. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
